The gadolinium market in Spain is expected to grow at a CAGR of 3.9% by 2034. Spain's leadership in medical tourism is supported by a reputable private healthcare sector, which attracts advanced ...
After a nearly 2-year study, the US Food and Drug Administration (FDA) has not found any evidence of adverse events from the brain's retention of gadolinium after MRI that uses gadolinium-based ...
Marignac first isolated gadolinia, an oxide of gadolinium (Gd), in 1880. Then, in 1886, Lecoq de Boisbaudran successfully separated the element from Mosander’s “yttria.” Gadolinium is present in ...
Camberley nurse Clare Garrett, 45, says she was left needing a wheelchair after she had a private MRI scan in June 2024 ...
Bracco Imaging announces European Commission extended marketing authorisation for Vueway in EU for use in paediatric patients under 2 years of age: Milan Wednesday, January 28, 20 ...
Please provide your email address to receive an email when new articles are posted on . The FDA is now requiring that gadolinium-based contrast agents carry new label warnings about the risk for ...
There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive decline, according to a new study. There is no evidence that accumulation in the brain of the element ...
Dublin, April 04, 2025 (GLOBE NEWSWIRE) -- The "Gadolinium (CAS 7440-54-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...
NEW ORLEANS — For contrast-enhanced imaging in multiple sclerosis (MS), all gadolinium-based agents accumulate in body tissue but to greatly varying degrees. While the long-term effect of gadolinium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results